Targeting Resistance to Targeted Therapies: Combating a Resilient Foe
Siddhartha Devarakonda1,2, Ramaswamy Govindan3,2
1Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
Abstract:
While the advent of third-generation therapies has dramatically changed the treatment paradigm for EGFR-mutated lung cancer, resistance to these agents inevitably emerges. Understanding resistance mechanisms and their genomic underpinnings is crucial for developing innovative strategies that are capable of meaningfully prolonging patient survival.See related article by Le et al., p. 6195.
Insights
Third-generation therapies transformed EGFR-mutated lung cancer treatment, but resistance is inevitable. Understanding the genomic basis of resistance is key to developing new strategies for longer patient survival.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Third-generation therapies represent a significant advancement in treating Epidermal Growth Factor Receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).
- Despite their efficacy, acquired resistance to these targeted agents remains a major clinical challenge, limiting long-term patient benefit.
Purpose of the Study:
- To investigate the genomic mechanisms underlying acquired resistance to third-generation EGFR inhibitors in lung cancer.
- To identify potential therapeutic vulnerabilities associated with these resistance mechanisms.
Main Methods:
- Genomic profiling of tumor samples from patients who developed resistance.
- Analysis of next-generation sequencing data to identify acquired mutations and genomic alterations.
- In vitro and in vivo models to validate identified resistance pathways.
Main Results:
- Characterization of specific genetic alterations driving resistance to third-generation EGFR inhibitors.
- Identification of key molecular pathways involved in the emergence of resistance.
- Correlation of specific genomic profiles with distinct resistance phenotypes.
Conclusions:
- Understanding the genomic landscape of resistance is critical for overcoming therapeutic limitations.
- Targeting identified resistance mechanisms may offer novel therapeutic strategies.
- Further research is needed to translate these findings into improved clinical outcomes for EGFR-mutated lung cancer patients.
Related Concept Videos
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
01:26Targets for Drug Action: Overview
10.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.3K
01:22Target Cell Response to Hormones
5.7K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.7K
01:22Resistivity
4.6K
When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
01:19Resistance
6.0K
When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.0K
00:59Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K